Skip to main content
. 2002 May;70(5):2715–2720. doi: 10.1128/IAI.70.5.2715-2720.2002

TABLE 1.

BCC strains used in this study

Strain Strain typea Source, locationb BCESMc cblAd Status at day 16 in vivo
B. multivorans (genomovar II)
    C5393 03 CF, Canada Persistent
    C3430 07 CF, Canada Cleared
    C1576 10 CF-e, UK Persistent
    C5274 12 CF, Canada Persistent
    FC147 12 CGD, USA Persistent
    C5568 19 CF, Canada Persistent
B. cepacia (genomovar III)
    C1257 01 CF-e, USA + Cleared
    C5424 02 CF-e, Canada + + Cleared
    K56-2 02 CF-e, Canada + + Cleared
    C6433 04 CF-e, Canada + Cleared
    Cep511 05 CF-e, Australia + Cleared
    C4455 06 CF-e, Canada + Cleared
    C1394 13 CF-e, UK + Cleared
B. stabilis (genomovar IV)
    C7322 16 CF, Canada Cleared
B. vietnamiensis (genomovar V)
    FC811 08 CF, USA Persistent
B. cepacia (genomovar VI)
    Cep873 10 CF, Canada Persistent
a

Strain type is the numerical randomly amplified polymorphic DNA type assigned previously to this fingerprint pattern (19).

b

CF, strain from a CF patient; CF-e, strain that has spread epidemically among patients with CF; CGD, infection of a chronic granulomatous disease patient; UK, United Kingdom; USA, United States.

c

BCESM, presence of B. cepacia epidemic strain marker (19).

d

cb1A, presence of cable pilus subunit gene (19).